Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 5(127), p. 957-967, 2022
DOI: 10.1038/s41416-022-01852-0
Links
Tools
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
Journal article published in 2022 by
Roberto Moretto 
,
Andrew Elliott,
Daniele Rossini,
Rossana Intini,
Veronica Conca ,
Filippo Pietrantonio ,
Andrea Sartore-Bianchi ,
Carlotta Antoniotti,
Cosimo Rasola,
Mario Scartozzi,
Massimiliano Salati,
Nicoletta Pella,
Maria Alessandra Calegari,
Martina Carullo,
Francesca Corti
and other authors.
,
Andrew Elliott,
Daniele Rossini,
Rossana Intini,
Veronica Conca ,
Filippo Pietrantonio ,
Andrea Sartore-Bianchi ,
Carlotta Antoniotti,
Cosimo Rasola,
Mario Scartozzi,
Massimiliano Salati,
Nicoletta Pella,
Maria Alessandra Calegari,
Martina Carullo,
Francesca Corti
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 